Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
6.00
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed

Precipio Revenue

Precipio had revenue of $5.21M in the quarter ending September 30, 2024, with 15.29% growth. This brings the company's revenue in the last twelve months to $17.41M, up 31.31% year-over-year. In the year 2023, Precipio had annual revenue of $15.20M with 61.46% growth.

Revenue (ttm)
$17.41M
Revenue Growth
+31.31%
P/S Ratio
0.50
Revenue / Employee
$305,456
Employees
57
Market Cap
8.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.20M5.79M61.46%
Dec 31, 20229.41M563.00K6.36%
Dec 31, 20218.85M2.76M45.26%
Dec 31, 20206.09M2.97M94.82%
Dec 31, 20193.13M263.00K9.18%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aytu BioPharma 79.76M
Jaguar Health 10.48M
Evogene 9.45M
Ensysce Biosciences 4.42M
RedHill Biopharma 3.71M
BioRestorative Therapies 377.00K
Soligenix 364.18K
Revenue Rankings